Secretin: a long progress note.
D000595:Amino Acid Sequence; D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D002766:Cholecystokinin / Q000494:pharmacology; D004064:Digestive System / Q000187:drug effects; D004285:Dogs; D005704:Gallbladder / Q000187:drug effects; D005750:Gastric Juice / Q000378:metabolism; D005934:Glucagon / Q000096:biosynthesis; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007413:Intestinal Mucosa / Q000378:metabolism; D008099:Liver / Q000187:drug effects; D010179:Pancreas / Q000187:drug effects; D010277:Parasympathomimetics / Q000494:pharmacology; D012633:Secretin / Q000032:analysis / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000302:isolation & purification / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D014630:Vagus Nerve / Q000502:physiology
D007328:Insulin; D010277:Parasympathomimetics; D012633:Secretin; D005934:Glucagon; D002766:Cholecystokinin; D005947:Glucose